DPPPRED-IV:一个集成的基于QSAR的Web服务器,用于预测二基酶4抑制剂
Laureano E Carpio1,2, Marta Olivares3, Rita Ortega-Vallbona2
1MolDrug AI Systems SL, Parque Tecnológico de Valencia, 46980 Valencia, Spain.
International journal of molecular sciences
|June 26, 2025
概括
研究人员开发了DPPRED-IV,这是一个使用定量结构活动关系 (QSAR) 模型的网络工具,用于预测2型糖尿病 (T2DM) 药物发现的二二酶4 (DPP4) 抑制剂.
科学领域:
- 计算化学的计算化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 是一种普遍的代谢障碍.
- 双基化酶4 (DPP4) 抑制剂是有效的T2DM治疗方法,但新型抑制剂的发现具有挑战性.
- 庞大的化学空间阻碍了新的DPP4抑制剂的鉴定.
研究的目的:
- 开发DPPPRED-IV,这是一个基于网络的整体系统,用于预测人类DPP4抑制活性.
- 整合二进制分类和连续回归定量结构活动关系 (QSAR) 模型.
- 为加速早期药物发现查提供一个用户友好的工具.
主要方法:
- 使用了一个精选的数据集,包含4,676种ChEMBL化合物.
- 使用了遗传算法描述器选择和多个机器学习算法.
- 使用集成方法 (软投票进行分类,回归用于IC50估计),并进行外部验证和适用性领域分析.
主要成果:
- 开发的DPPPPRED-IV系统集成了分类和回归QSAR模型.
- 外部验证证实了这些模型的强度.
- 对29种化合物的实验测试显示,14种预测的活性物体表现出显著的DPP4抑制.
结论:
- DPPRED-IV准确地预测了DPP4抑制活性,有助于早期药物查.
- 网络服务器可以从SMILES输入中进行预测,从而加速决策.
- 这种工具降低了T2DM药物发现中的成本和动物使用.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
271
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
271
02:04Protein-protein Interfaces
13.7K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.7K